Kamada KMDA
NASDAQ KMDA
$8.20 -0.26 (-3.07%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kamada (KMDA) Gross Profit (2012 - 2026)

Updated

Kamada's Gross Profit was $22.47 million in the quarter ended Jun 30, 2026, up 18.7% from $18.93 million a year earlier and up 17.5% from the prior quarter.

Analysis

Kamada (KMDA) Gross Profit (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Kamada's Gross Profit was $78.31 million through Jun 30, 2026, up 5.9% year-over-year; for the year ended Dec 31, 2025, it was $76.41 million, up 9.2% from the prior year.

  • Gross Profit has now increased for four consecutive years, with a five-year compound annual growth rate of 9.9% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Gross Profit was $69.97 million in the year ended Dec 31, 2024 (+26.1%), $55.49 million in the year ended Dec 31, 2023 (+18.8%), $46.7 million in the year ended Dec 31, 2022 (+54.0%) and $30.33 million in the year ended Dec 31, 2021 (-36.2%).
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Gross Profit in data going back to the quarter ended Jun 30, 2012.
  • Compared with a year earlier, Gross Profit was higher in five of the last eight quarters, with growth averaging 10.4%.
  • The best year-over-year quarter for Gross Profit over five years was the quarter ended Dec 31, 2022 (growth of 131.9%); the worst was the quarter ended Sep 30, 2021 (a decline of 61.3%).
  • Per Business Quant data, KMDA's Gross Profit in the three quarters before the quarter ended Jun 30, 2026 was $19.12 million (quarter ended Mar 31, 2026), $16.97 million (quarter ended Dec 31, 2025) and $19.76 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.47 Mn
Mar 31, 2026 19.12 Mn
Dec 31, 2025 16.97 Mn
Sep 30, 2025 19.76 Mn
Jun 30, 2025 18.93 Mn
Mar 31, 2025 20.75 Mn
Dec 31, 2024 17.03 Mn
Sep 30, 2024 17.23 Mn
Jun 30, 2024 18.95 Mn
Mar 31, 2024 16.75 Mn
Dec 31, 2023 14.41 Mn
Sep 30, 2023 14.80 Mn
Jun 30, 2023 14.44 Mn
Mar 31, 2023 11.84 Mn
Dec 31, 2022 15.29 Mn
Sep 30, 2022 12.87 Mn
Jun 30, 2022 7.24 Mn
Mar 31, 2022 11.30 Mn
Dec 31, 2021 6.60 Mn
Sep 30, 2021 5.73 Mn
API Access

Kamada Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=KMDA&period=max&api_key=YOUR_API_KEY